Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Joan A. Barbera"'
Autor:
Steven D. Nathan, Scott D. Barnett, Christopher S. King, Steeve Provencher, Joan A. Barbera, Jean Pastre, Oksana A. Shlobin, Werner Seeger
Publikováno v:
Pulmonary Circulation, Vol 11 (2021)
The implications of the recent change in the definition of pulmonary hypertension on epidemiology and outcomes are not known. We sought to determine the percentage of patients with the two most common lung diseases that would be reclassified regardin
Externí odkaz:
https://doaj.org/article/82ac657ffc274938896da427adfb5fe9
Autor:
Chiara de Waure, Barbara C. Gärtner, Pier Luigi Lopalco, Joan Puig-Barbera, Jonathan S. Nguyen-Van-Tam
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 27-38 (2024)
ABSTRACTIntroduction Influenza causes significant morbidity and mortality, but influenza vaccine uptake remains below most countries’ targets. Vaccine policy recommendations vary, as do procedures for reviewing and appraising the evidence.Areas Cov
Externí odkaz:
https://doaj.org/article/4c20478743b149ac8fc52bacac37208f
Autor:
Mahrukh Imran, Joan Puig-Barbera, Justin R Ortiz, Lauren Fischer, Dan O’Brien, Machaon Bonafede, James A Mansi, Constantina Boikos
Publikováno v:
Open Forum Infectious Diseases. 9
Background Age-related immunosenescence may impair the immune response to vaccination in older adults. Adjuvanted influenza vaccines are designed to overcome immune senescence in older adults. This study estimated the relative vaccine effectiveness (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d231cfd9714b9fb6f1efc1bdacdca53e
https://doi.org/10.1093/ofid/ofac167
https://doi.org/10.1093/ofid/ofac167
Autor:
Thierry Rigoine de Fougerolles, Oliver Damm, Filippo Ansaldi, Maria Chironna, Pascal Crépey, Simon de Lusignan, Ian Gray, José Maria Guillen, George Kassianos, Anne Mosnier, Raul Ortiz de Lejarazu, Elena Pariani, Joan Puig-Barbera, Jörg Schelling, Francesca Trippi, Philippe Vanhems, Klaus Wahle, John Watkins, Anvar Rasuli, Olivier Vitoux, Hélène Bricout
Publikováno v:
BMC Public Health
BMC Public Health, 2022, 22 (1), pp.1151. ⟨10.1186/s12889-022-13433-0⟩
r-FISABIO. Repositorio Institucional de Producción Científica
instname
BMC Public Health, 2022, 22 (1), pp.1151. ⟨10.1186/s12889-022-13433-0⟩
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Background Influenza surveillance systems vary widely between countries and there is no framework to evaluate national surveillance systems in terms of data generation and dissemination. This study aimed to develop and test a comparative framework fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ba581308fd6f7d670ec46b4691acb76
https://hal.ehesp.fr/hal-03700659/document
https://hal.ehesp.fr/hal-03700659/document
Autor:
Thierry Rigoine de Fougerolles, Joan Puig‐Barbera, George Kassianos, Philippe Vanhems, Jorg Schelling, Pascal Crepey, Raul Ortiz Lejarazu, Filippo Ansaldi, Markus Fruhwein, Cristina Galli, Anne Mosnier, Elena Pariani, Anvar Rasuli, Olivier Vitoux, John Watkins, Thomas Weinke, Hélène Bricout
Publikováno v:
Influenza and Other Respiratory Viruses
Influenza and Other Respiratory Viruses, 2022, 16 (3), pp.417-428. ⟨10.1111/irv.12941⟩
Influenza and Other Respiratory Viruses, 2022, 16 (3), pp.417-428. ⟨10.1111/irv.12941⟩
Background\ud In response to the coronavirus disease (COVID-19) outbreak that unfolded across Europe in 2020, the World Health Organisation (WHO) called for repurposing existing influenza surveillance systems to monitor COVID-19. This analysis aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6f8c135f5afc5f988a8ee80107f4c3e
https://doi.org/10.22541/au.163629278.88925629/v1
https://doi.org/10.22541/au.163629278.88925629/v1
Publikováno v:
In Revista Española de Cardiología (English Edition) 2010 63(5):583-596
Autor:
Agustin R. Garcia, Isabel Blanco, Lluis Ramon, Jesús Pérez-Sagredo, Francisco J. Guerra-Ramos, Clara Martín-Ontiyuelo, Olga Tura-Ceide, Francisco Pastor-Pérez, Pilar Escribano-Subías, Joan A. Barberà
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Background Achieving and maintaining a low-risk profile is associated with favorable outcome in pulmonary arterial hypertension (PAH). The effects of treatment on risk profile are variable among patients. Objective To Identify variables that
Externí odkaz:
https://doaj.org/article/9314f451030f46a088b5953180dd8686
Autor:
Charles P. Andrews, Myron J. Levin, Tino F. Schwarz, Lily Yin Weckx, Lidia Oostvogels, Covadonga Caso, Anthony L. Cunningham, Won Suk Choi, Angelo Pellegrino, Maria Luisa Rodriguez de la Pinta, Joon Hyung Kim, Tiina Korhonen, Edward M. F. Leung, Peter Eizenberg, Jackson H. Downey, David S.C. Hui, Janet E. McElhaney, Azhar Toma, Lars Rombo, Shelly A. McNeil, Wayne Ghesquiere, Roman Chlibek, Ilkka Seppa, Juan Carlos Tinoco, Silvia Narejos Perez, Daisuke Watanabe, Abiel Mascarenas de Los Santos, David O. Willer, Romulo E Colindres, Jose-Fernando Barba-Gomez, Anitta Ahonen, Anne Schuind, Carles Brotons Cuixart, Ferdinandus de Looze, Tommaso Staniscia, Alexander L. Thompson, Yeo Wilfred, Shinn-Jang Hwang, Iris Gorfinkel, Javier Díez Domingo, Meral Esen, Carla A. Talarico, Eugene Athan, Airi Poder, Johan Berglund, Jan Smetana, Pierre Gervais, Valentine Wascotte, Robert W. Johnson, Thiago Junqueira Avelino-Silva, Hideyuki Ikematsu, Karlis Pauksens, Maria Giuseppina Desole, Toufik Zahaf, Rodrigo Ribeiro dos Santos, Joan Puig Barbera
Publikováno v:
Vaccine. 37(43)
Background Herpes zoster (HZ) risk appears to vary by sex and geographic ancestry/ethnicity. Methods In 2 randomized clinical trials, participants received 2 doses of adjuvanted recombinant zoster vaccine (RZV) or placebo intramuscularly, 2 months ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15c5902400bff974cc20b7af1945a024
https://pubmed.ncbi.nlm.nih.gov/31537443
https://pubmed.ncbi.nlm.nih.gov/31537443
Publikováno v:
Vaccine. 33:2183-2188
Objective To develop a method to estimate vaccination coverage using both a computerized vaccine registry with an unknown underreporting rate and a seroprevalence study. A real example of a meningococcal C conjugate vaccine (MCCV) coverage estimation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112cb161a38fdf2bd1bbab272830b2d0
https://doi.org/10.1016/j.vaccine.2015.02.048
https://doi.org/10.1016/j.vaccine.2015.02.048
Autor:
Alberto Arnedo-Pena, Juan Bellido-Blasco, Joan Puig-Barbera, Adrián Artero-Civera, Joan Baptista Campos-Cruañes, Mª Rosario Pac-Sa, Jose Luis Villamarín-Vázquez, Carlos Felis-Dauder
Publikováno v:
Salud Pública de México, Vol 49, Iss 4, Pp 295-301 (2007)
OBJETIVO: Estudiar la asociación entre la prevalencia de eczema atópico (EA) y la dureza del agua de uso doméstico. MATERIAL Y MÉTODOS: El estudio ISAAC (International Study of Asthma and Allergies in Childhood) estimó la prevalencia de EA en se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::0737a9b0f9fcef636713bab6ed66b23c
http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342007000400009
http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342007000400009